Since 1994, the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) team, led by Dr. Kenneth Freedberg at the Massachusetts General Hospital, has used a Monte Carlo simulation model to evaluate the cost-effectiveness of national and multinational strategies for combating HIV/AIDS. The model, first developed in response to the outbreak of the HIV/AIDS epidemic in the United States, has grown over time in both scope and application to provide comprehensive analyses for prospective treatment strategies of HIV/AIDS and AIDS-related complications, including tuberculosis and other infections.

The CEPAC team collaborates with research teams in Côte d’Ivoire, France, India, South Africa, and Zimbabwe, as well as investigators from Brigham and Women’s Hospital, the Harvard School of Public Health, Weill Cornell Medical College, and Yale University. Research from the CEPAC team has been published in several leading medical journals, including the Journal of the American Medical Association, New England Journal of Medicine, and AIDS.  In December of 2008, the team won the Partners in Excellence award for Outstanding Teamwork.

Last Updated (Friday, 30 October 2009 15:03)